Bluetongue (BT) is a ruminant viral infectious disease transmitted by Culicoides spp.
| INTRODUCTION
Bluetongue (BT) is a non-contagious arthropod-transmitted viral disease of ruminants caused by bluetongue virus (BTV) and transmitted by Culicoides spp. (Sperlova & Zendulkova, 2011) . BTV is a doublestranded RNA virus belonging to the Orbivirus genus in the Reoviridae family and includes a total of 27 BTV different serotypes that have been described up to now . BT can cause mild to large scale outbreaks and therefore appears on the list of the World Organisation for Animal Health (OIE) notifiable diseases (Council Directive 2000/75, World Organisation for Animal Health, 2017) . BT clinical signs are typically observed in sheep but BTV serotype 8 (BTV-8) also induces mild infection in cattle (conjunctivitis, lesions of nasal mucosa, skin lesions, nasal discharge, lethargy, drop in milk production) (Zanella et al., 2013) . BT has a significant economic impact due to the disease effect on animal health (morbidity, mortality, reproductive failure, reduction in milk production and weight loss) and, most of all, to the disruption of international trade of animals and animal products (Saegerman, Berkvens, & Mellor, 2008) .
Before 1998, BT infection was restricted to temperate and tropical regions of the world which coincide with the distribution of the historical main competent vector, Culicoides imicola (Zientara & Sanchez-Vizcaino, 2013) . However, from 1998 to 2005, the area of C. imicola extended gradually to the North (Jacquet et al., 2015) . In addition, other culicoides species abundant in Northern Europe (i.e., Culicoides obsoletus, Culicoides pulicaris) have been reported to be competent vectors for BTV-8 (Benelli et al., 2017; Carpenter, Wilson, & Mellor, 2009) . In 2006, BTV-8 emerged for the first time in Northern Europe (France, Belgium, Germany, Luxembourg, the Netherlands) and rapidly spread through Europe in the following years (Carpenter et al., 2009) . By the end of the first epidemic in December 2006, a total of 695 outbreaks were reported in Belgium (Méroc et al., 2009 ). This epidemic induced considerable losses in Belgium estimated at 205€ per beef cattle, 233€ per dairy cattle and 55€ per infected sheep (Hanon et al., 2009 ). In 2007 other regions of Europe and the number of outbreaks increased rapidly. At the end of the year 2007, a total of 6,870 outbreaks were reported throughout Belgium (Méroc et al., 2009 ). In September of 2015, an outbreak of BTV-8 was reported in France which was the first outbreak of this serotype in the EU since 2011 and new cases are now frequently and officially reported in this country. Due to the risk for re-introduction, preventive vaccination would help Belgium keep its status of freedom from infection of BTV-8. To subsidize, it could be an incentive to convince more farmers to vaccinate but both decision-makers and stakeholders should be of these three-first WSs were analyzed. These WSs were undertaken in the same cattle herds (Méroc et al., 2008 (Méroc et al., , 2009 ) and the WS characteristics are summarized in Table 1 . Only cattle were sampled in the WS programme and neither goats nor sheep are part of this screening. The serum samples were analyzed using the "ID Screen1
Bluetongue Competition" assay (ID VET, Montpellier-FRANCE) according to the manufacturer's instructions but with the cut-off determined by Vandenbussche et al. (2008) . Results were expressed as percentage negativity (PN% = [optical density sample/optical density negative kit control] × 100). Non-interpretable results due to bad quality sampling were deleted from the final datasets. The serological results from the WSs were evaluated by first estimating the three within-herd seroprevalences using logistic-normal regression CARGNEL ET AL.
| 401 models (SAS Inc, Version 9.2). In order to make these seroprevalences comparable from one to the other, the estimations were restricted to adult animals. The true prevalences, reflecting the real serological status of the animals, were derived by taking the sensitivity (87.8%) and the specificity (98.2%) of the competitive ELISA test into account (Rogan & Gladen, 1978; Vandenbussche et al., 2008) .
| Virological data
During WS3 (after vaccination), because of absence of Differentiation of Infected and Vaccinated Animals (DIVA) ELISA, infected animals were identified by collecting uncoagulated blood samples (EDTA) by the official farm veterinarians and samples were conditioned at the regional laboratories of "Dierengezondheidszorg Vlaanderen" and the "Association Regionale de Sante et d'Identification
Animales". The EDTA samples were analyzed at CODA-CERVA with a RT-qPCR as described by Vandenbussche et al. (2008) . Based on a cut-off set at a Ct-value of 40, results were defined as "positive" (<40) or "negative" (≥40).
| Vaccination data
During the vaccination campaign, information on the vaccination progress (date of the first and second injection of the primo vaccination rounds) was recorded by the Belgian Federal Agency for the Safety of the Food Chain (FASFC) and was extracted and analyzed for each livestock herd sampled within the WSs.
| Change in individual serological profiles between WS2 and WS3
In order to evaluate the individual serological profiles between WS2 (before the vaccination campaign) and WS3 (during or after the vaccination campaign), the following variables were created:
• "QuantiWS2" and "QuantiWS3" were defined as the PN% obtained by subtracting the PN% values at WS2 and WS3 (continuous variables) from 100 in order to display an increased antibody response when there is truly an increase of antibodies.
• "Change" (%), a continuous variable obtained by subtracting QuantiWS2 from QuantiWS3, indicates for the cattle the change in serology between WS2 (before vaccination) and WS3 (during or after vaccination).
• "StatusWS1", a dichotomous variable indicating whether the cattle came from a herd where within-herd seroprevalence in WS1 was above the mean prevalence of 27% or not (Méroc et al., 2008) .
• "Time", a continuous variable reflecting the number of months between the date of first injection at herd level and the sampling date of the individual cattle. After consideration of the variable's histogram which clearly showed a bimodal pattern, it was decided to create from it a dichotomous variable determining if "Time" was superior to 3 months (=1) or not (=0).
• "Two injections", a dichotomous variable indicating whether the cattle had received its second vaccination (=1) or not yet (=0) at moment of sampling.
• "Age" (months), a continuous variable indicating the age of the cattle. This was extracted from the central identification and registration system of the FASFC (SANITRACE).
The profiles of cattle, strictly seropositive at WS2 (n = 2,360) were compared to animals strictly seronegative at WS2 (n = 199) (=inde-pendent variable). For the later, the effects of vaccination variables ("Time", "Two injections"), "StatusWS1" and "Age" on the "Change" were analyzed at animal level (=dependant variables). First, univariate associations between the response "Change" and the different categorical independent variables ("Time", "Two injections" and "Status WS1") were explored using one-way ANOVAs. The clustering within the herds was not taken into account in this part of the analysis. Residual plots were used to ensure that the assumptions underlying the ANOVAs were met. Then, a linear mixed model which takes into account the correlation among animals from the same herd, by adding a random herd effect, was used for multivariable modelling (Dohoo, Martin, & Stryhn, 2003b the better a particular model fits (Akaike, 1974) . A probability value of <0.05 indicated a statistically significant result. To assess the validity of the model, standardized residuals were computed and graphical methods were used. The homoscedasticity assumption was verified by plotting the standardized residuals against the predicted means and a normal probability plot for the residuals was used to examine the normality.
| RT-PCR positives
The univariate association between the RT-PCR status and the age of the cattle was explored by means of a marginal model, using the generalized estimating equation (GEE), which takes into account the clustering within herds (Liang & Zeger, 1986) . A dichotomous variable "seroWS2" was created where "seroWS2" = 1 when in a herd at least one animal remained seronegative at WS2. The effects of the vaccination variables, status2007 and seroWS2 on the RT-PCR status of the herd were analyzed using multivariable logistic regression. The best model was selected by comparing AIC estimates of all possible models with main effects and their two-way interactions.
The Hosmer-Lemeshow goodness-of-fit test was used to assess the fit of the model (Dohoo, Martin, & Stryhn, 2003a) . The results for the risk factors, from fitting the final model, were expressed as odds ratios along with their corresponding 95% confidence intervals and probability values. A probability value of <0.05 indicated a statistically significant result.
| Cost-benefit analysis

| Data
Bovine and ovine population data regarding herd type and associated herd size were obtained from SANITEL and National Institute of Statistics in 2015 ( Table 3 .
For infected herds, impact on production per herd was based on the sum of costs linked to mortality and reproductive performance disorders for each herd type. Drop in milk production was only accounted for as production loss in the herd category dairy. described above linked to the epidemic and different vaccination strategies were fitted into an adapted version for Belgium of the model described. It is assumed that vaccination will induce full clinical protection and, as a consequence, the production and treatment costs linked to an epidemic will be absent.
The benefit (B) is modelled for every given herd category type (i), as a function of avoided cost linked to productivity loss (P i ; linked to mortality, reproductive performance disorders and drop in milk production [only dairy farms]), treatment (T i ), and preventive management costs (linked to insect repellents, price variation linked to movement and export losses; M i ; Equation (1))
| Cost of vaccination
Cost of vaccination strategy (C), was modelled as a function of the number of vaccinated farms (nh) times the number of doses (d) per vaccinated animal times the sum of veterinary call out fee (Vet), number of cattle (na) within the farm vaccinated together with the cost per vaccine dose (V) as well as the vaccination administration fee (F) for each given herd category type (i; Equation (2)).
Data were entered in an economic stochastic iteration model taking into account variability and uncertainty linked to expected herd sizes per herd category. Different expected BTV prevalence (mean = 50%; min-max = 16-82) were tested in three separate scenarios. The economic criteria were assessed at farm and country level looking at benefit-cost ratio and total net returns. The benefitcost ratio is the ratio of the total production losses avoided divided by the total vaccination cost. The total net returns equal the total benefits minus the total costs and indicates how high the extra benefits are in relation to the costs.
| Number of vaccinated herds during the voluntary and subsidized vaccination campaign
To 
| Change in individual serological profiles between WS2 and WS3
Using a cut-off level of quantiWS2 > 35%, it appears that 88% of cattle were already highly seropositive (quantiWS2 > 80%) at WS2
and stayed highly positive at WS3. A portion of animals however,
were highly positive at WS2 and became less positive at WS3 (quantiWS3 < 80%; 9% of animals) or even negative (quantiWS3 < 25%; 5% of animals).
The quantiWS3 distribution of cattle seronegative at WS2 is presented in Figure 1 . Eighty percent of those animals became seropositive (quantiWS3 > 25%).
From 199 cattle, we could extract data for which WS2 and WS3 serological responses were available and that were seronegative at quantiWS2 (using a cut-off level of quantiWS2 < 25%).
For those animals, quantiWS3 was significantly higher (mean = 59; SD = 33.33) than quantiWS2 (mean = 4.6; SD = 6.61; Based on Table 5 , the bovine animals with a longer duration between first vaccine injection and sampling ("Time" = 1) have a superior "Change" on average than the others which highlights the efficiency of the vaccine to induce antibodies. In the same way, subjects which had received two vaccine injections at sampling time ("Two injections" = 1) had a significantly higher "Change" than those that received only one vaccination which pinpoints the importance of respecting the vaccination protocol in its entirety in due time.
The results of the multivariable model at the cattle level are presented in Table 6 . It appears that after taking into account all independent covariates simultaneously and adjusting for herd effect, the only significant effect was the interaction between "Time" and "Two injections". Table 7 describes the mean "Change" for each of the patterns formed by combining "Time" and "Two Injections". The results
show that by themselves "Time" (48.6% − 31.2% = 17.4%) and "Two injections" (70.4 − 31.2 = 39.2%) makes "Change" increase. However, when those factors are both present, instead of adding the sum of the two main effects (17.44% + 39.22% = 57%) to the baseline level of mean "Change", only 61.53% − 31.2% = 30.33% is added.
Considering only bovine animals with "Two injections = 1", time between this last injection and sampling was significantly shorter in the group with "Time = 0" (9.5 days) compared to the group with "Time = 1" (51.3 days; p-value < 0.001).
| RT-PCR positives
Out Table 8 presents the estimated odds ratios from the multiple logistic regression model at the herd level. The results showed that "StatusWS1", "Time", "Two injections" and "SeroWS2" acted as protective factors on the risk of being RT-PCR positive (OR < 1). However, none of these effects were statistically significant.
| Cost-benefit analysis
| Cost benefit and total net returns for voluntary vaccination at farm level
The total net returns which is the benefit gained by avoiding losses (productivity losses, treatment and preventive measures) compared to the vaccination cost were always positive and ranging from 1,000 up to 10,000 euros per farm with the exception of fattening calves, due to their short lifetimes (Figure 2) . (=1) or not yet (=0) at moment of sampling. StatusWS1: indicates whether the cattle came from a herd where within-herd seroprevalence in WS1 was above the mean prevalence of 27% or not.
The ratio of benefits over vaccination cost was always greater than one, with the exception of fattening calves illustrating the nonprofit action of vaccination in that category (Figure 3 ).
| Cost benefit and total net returns for mandatory vaccination at country level
The observations made at farm level were even more obvious at country level, where the net return was even greater ranging from 1 million euros up to 10 million euros and above, with the exception of fattening calves illustrating again the non-profit action of vaccination in that category (Figures 4 and 5 ).
| Number of vaccinated herds during the voluntary and subsidized vaccination campaign
Voluntary and subsidized vaccinations led to an important increase in the number administered during the first month: 9,246 cattle and 1,599 sheep herds out of the 24,000 total Belgian bovine and 25,000
sheep herds in April 2016. During the whole study period, more than 15,000 cattle and 3,227 sheep herds were vaccinated (Figure 6 ).
| DISCUSSION
The results of the three-first cross-sectional studies in Belgian cattle showed that the mandatory vaccination campaign permitted the seroprevalence level to nearly reach 100% since the end of the second episode of BTV-8 (WS2) and the majority of the population remained seropositive at WS3. The serological profiles of cattle still seronegative before the vaccination campaign was interesting since it turned out that 80% of these animals had seroconverted at WS3.
Antibodies can appear as early as the sixth post-infection day (Sperlova & Zendulkova, 2011) and this immunity may last for several years (Oura et al., 2012) .
In a certain proportion of animals, a decrease in the serologic response was observed between the 2 years. This could be linked to Notes. Time: number of months between the date of first injection at herd level and the sampling date of the individual cattle: if "Time" was superior to 3 months (=1) or not (=0). Two injections: indicates whether the cattle had received its second vaccination (=1) or not yet (=0) at moment of sampling. StatusWS1: indicates whether the animal came from a herd where within-herd seroprevalence in WS1 was above the mean prevalence of 27% or not. SeroWS2 = 1 when on a herd at least one animal remained seronegative at WS2.
Significant univariate associations were found between the individual change in serology on one hand and "Time" and "Two Injections" on the other hand. Indeed, the vaccine producers indicated in their leaflet (European Medicines Agency, 2011 ) that the inactivated vaccines should be administrated in two separate doses and that the onset of immunity occurs more or less 3 weeks after administration of the second injection. These findings pinpoint the importance of respecting the vaccination protocol in its entirety and of vaccinating in due time.
Multivariate modelling showed a significant interaction between "Time" and "Two Injections". For those cattle that had received the second injection at sampling time, a longer time since first injection ("Time" = 1) was associated to a lower "Change". This association seems to reflect the decrease of the serologic response after reaching a peak linked to the second injection, since it was also shown that "Time" was positively correlated with the time between second injection and sampling. The evaluation of vaccination could only be done on 199 animals as these animals were the only ones still seronegative just before vaccination, while all the others were already seropositive. Another drawback is that vaccination variables were solely available at herd level. Thus, individual variation within herds regarding the risk factors could not be accounted for in the analysis and this may have induced a bias.
We could have expected a difference in age between PCR positive and negative cattle, with more animals being younger in the group of positives because less protected (lower seroprevalence and no vaccination in young calves). However, no age difference was detected between the positive and negative groups. The findings of the multivariable study showed that the vaccination and serology variables were protective factors but did not indicate a significant effect of any of these, except for the time since first injection that was borderline significant.
F I G U R E 2 Expected cost of an bluetongue virus serotype 8 epidemic in case of no vaccination (=mean vaccination "benefit") compared to vaccination cost per farm for each defined herd category F I G U R E 3 Net difference cost in euros of average production losses cost minus bluetongue virus serotype 8 vaccination costs and ratio of average production losses over vaccination cost per farm for each defined herd category Unfortunately, because of a lack of positive cases (2.5% of animals sampled) and no vaccination data at animal level, all risk factors except for age could not be studied at animal level. Other extrinsic factors such as conservation of the doses, the way administration was performed, or animal health at time of injection were not considered at all in the multivariable analysis and obviously are critical points which should be accounted for.
Vaccination is the cheapest effective measure to prevent the spread of BTV infection and consequences thereof. This study also clearly demonstrates and confirms the benefit of vaccination by reducing economic impact of treatment and production losses in Belgium, as already published by others (Spedicato et al., 2017; Zientara & Sanchez-Vizcaino, 2013) . This beneficial effect of vaccination is principally observed in dairy cattle which suffered higher economic losses during the 2006-2007 epidemic compared to sheep farms and fattening calves (Hanon et al., 2009 ).
The reduction in transmission rate and its benefit for non-vaccinated animals was not accounted for in the current study but several studies have clearly demonstrated the effect of vaccination in reducing spread even though not preventing it (Pioz et al., 2011; Szmaragd et al., 2010; Zientara & Sanchez-Vizcaino, 2013) . Therefore, we expect the benefits in our case to be more important than in the Dutch study. As for the Netherlands, the model also predicts that the major losses due to the epidemic (production, diagnosis, treatment and control) would be for the cattle dairy export firms and the dairy farms. The model also predicts that vaccinating goats F I G U R E 4 Expected cost of an epidemic in case no bluetongue virus serotype 8 vaccination compared to vaccination cost at country level for each defined herd category F I G U R E 5 Net difference in euros of average production losses cost minus bluetongue virus serotype 8 vaccination costs and ratio of average production losses over vaccination cost at country level for each defined herd category and animals from hobby farms is not cost efficient in a time horizon of a year.
However, vaccination costs in the Dutch study is almost twice as high for the cattle sector than for the sheep and goat sectors mainly because it was considered that cattle had to be vaccinated twice (two doses per cattle versus one dose per sheep and goat). In the Netherlands, the benefit-cost ratios of the sheep and cattle sectors exceed one for all strategies and the ratios of the sheep sector for all vaccination strategies are higher than the cattle sector ratios. In Belgium, the benefit-cost ratios of the fattening calves are expected to be lower than one and the ratios of the sheep sector are not higher than ratios of the other categories. However, without a continuous vaccination programme, we should be aware that the virus could contaminate all newborn animals and that part of the cattle population will continuously remain susceptible. Another factor which influences the change in withinherd seroprevalence from one WS to the other is animal movement.
For example, importation or birth of animals from a BTV-8 non-vaccinated area into a vaccinated herd will contribute to make its global serology level decrease.
In addition, participation in epidemiological studies and financing of vaccination programmes should not be restrained at country level because BTV is a European concern. With the long-term perspective of controlling the spread of BTV-8 and eradicating the disease, which requires 5 years of vaccination of 95% of susceptible cattle and sheep (European Food Safety Authority, 2017), we should encourage countries to participate in large scale epidemiological studies, and plan to face them together such as initiated in several EU research projects (Ruegg et al., 2018; Welby et al., 2017) .
| CONCLUSION
In 
